Lyell Immunopharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MWG MANAGEMENT LTD. | 05/13/2025 | 20.16 M | $10.85 M | 0.00% | 6.83% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 05/15/2025 | 16.01 M | $8.61 M | 92.29% | 5.42% |
ORLAND PROPERTIES LTD | 05/13/2025 | 15.09 M | $8.15 M | 0.00% | 5.11% |
BLACKROCK, INC. | 05/02/2025 | 12.72 M | $6.84 M | -4.10% | 4.31% |
DECHENG CAPITAL LLC | 05/08/2025 | 11.91 M | $6.41 M | 0.00% | 4.04% |
VANGUARD GROUP INC | 05/09/2025 | 9.74 M | $5.24 M | -0.29% | 3.30% |
FORESITE CAPITAL MANAGEMENT V, LLC | 05/15/2025 | 8.13 M | $4.38 M | 0.00% | 2.76% |
VENBIO PARTNERS LLC | 05/15/2025 | 7.10 M | $3.82 M | 0.00% | 2.41% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 6.48 M | $3.49 M | -6.25% | 2.20% |
ALPHABET INC. | 05/02/2025 | 5.87 M | $3.17 M | 0.00% | 1.99% |
CITADEL ADVISORS LLC | 05/15/2025 | 4.51 M | $2.35 M | 20.03% | 1.53% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 4.40 M | $2.37 M | 6.33% | 1.49% |
STATE STREET CORP | 05/15/2025 | 3.70 M | $1.99 M | -1.23% | 1.25% |
SC CHINA HOLDING LTD | 05/13/2025 | 3.05 M | $1.46 M | 0.00% | 1.03% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.77 M | $951.45 K | 9.70% | 0.60% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.60 M | $863.32 K | -2.50% | 0.54% |
NORTHERN TRUST CORP | 05/13/2025 | 1.30 M | $696.75 K | -1.16% | 0.44% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 1.00 M | $540.50 K | 0.00% | 0.34% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 876.04 K | $471.31 K | -31.35% | 0.30% |
MORGAN STANLEY | 05/15/2025 | 866.40 K | $466.13 K | -28.65% | 0.29% |
JOHNSON & JOHNSON | 05/07/2025 | 823.32 K | $442.95 K | 0.00% | 0.28% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 660.90 K | $354.00 K | 204.16% | 0.22% |
05/12/2025 | 641.17 K | $344.95 K | 100.00% | 0.22% | |
CANADA PENSION PLAN INVESTMENT BOARD | 05/15/2025 | 588.24 K | $316.47 K | 0.00% | 0.20% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 558.98 K | $300.73 K | -59.65% | 0.19% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 525.78 K | $282.87 K | 0.00% | 0.18% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 513.83 K | $276.44 K | -6.89% | 0.17% |
CLARIUS GROUP, LLC | 04/18/2025 | 399.17 K | $214.75 K | 0.00% | 0.14% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 391.20 K | $210.47 K | 27.68% | 0.13% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 387.68 K | $208.57 K | 89.57% | 0.13% |
INVESCO LTD. | 05/12/2025 | 378.88 K | $203.84 K | -6.96% | 0.13% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 358.59 K | $192.92 K | -42.84% | 0.12% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 295.65 K | $159.06 K | -4.18% | 0.10% |
EXCHANGE TRADED CONCEPTS, LLC | 04/17/2025 | 246.35 K | $132.54 K | 82.41% | 0.08% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 244.71 K | $131.66 K | -39.76% | 0.08% |
RHUMBLINE ADVISERS | 05/29/2025 | 235.69 K | $126.79 K | -16.16% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 234.94 K | $126.40 K | 27.59% | 0.08% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 220.79 K | $118.79 K | 0.00% | 0.07% |
SQUAREPOINT OPS LLC | 05/15/2025 | 198.32 K | $106.70 K | 100.00% | 0.07% |
JPMORGAN CHASE & CO | 05/12/2025 | 194.65 K | $104.72 K | -55.07% | 0.07% |
BARCLAYS PLC | 05/15/2025 | 183.47 K | $99.00 K | -28.99% | 0.06% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 174.28 K | $93.76 K | 773.49% | 0.06% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 166.25 K | $89.44 K | -34.46% | 0.06% |
BBR PARTNERS, LLC | 05/14/2025 | 164.04 K | $88.25 K | 0.00% | 0.06% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 158.00 K | $85.00 K | 100.00% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 124.70 K | $67.09 K | 80.14% | 0.04% |
TUDOR INVESTMENT CORP ET AL | 05/15/2025 | 124.32 K | $66.88 K | 0.00% | 0.04% |
CITIGROUP INC | 05/12/2025 | 117.91 K | $63.43 K | -10.59% | 0.04% |
UBS GROUP AG | 05/13/2025 | 110.40 K | $59.40 K | -87.23% | 0.04% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 96.45 K | $51.89 K | 2.26% | 0.03% |
Lyell Immunopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Lyell Immunopharma, Inc.. The most heavily invested institutionals were:
MWG Management Ltd.: 20.16 M
Foresite Capital Management IV, LLC: 16.01 M
Orland Properties Ltd: 15.09 M
BlackRock, Inc.: 12.72 M
Decheng Capital LLC: 11.91 M
VANGUARD GROUP INC: 9.74 M
49.92% of Lyell Immunopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 184.86 M shares in the last 24 months. This purchase volume represents approximately $1.79 B in transactions.